跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allerta Junior - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Allerta Junior
Approved
STANDARD
Allerta Junior
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a7f89b4ae8fd479f
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a7f89b4ae8fd479f
Drug Approval Philippines Name
Allerta Junior
Product Name
Allerta Junior
Registration Number
DR-XY29918
Brand Name
Allerta Junior
Generic Name
Loratadine
Dosage Form
Syrup
Dosage Strength
5 mg/5 mL
Manufacturer
Amherst Laboratories, Inc.
Trader
Unilab, Inc.
Issuance Date
28 September 2020
Expiry Date
08 November 2025
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a7f89b4ae8fd479f
Type
Standard
Back to Philippines FDA Approvals